Portfolio Building Block World Pharma and Biotech Index ETF
PBPH
9 hedge funds and large institutions have $855M invested in Portfolio Building Block World Pharma and Biotech Index ETF in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
17% more capital invested
Capital invested by funds: $732M → $855M (+$123M)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
2.35% less ownership
Funds ownership: 102.88% → 100.54% (-2.3%)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
18% less funds holding
Funds holding: 11 → 9 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$77.1M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$306K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$28.7K |
| 4 |
CI
CX Institutional
Auburn,
Indiana
|
+$27.2K |
| 5 |
AF
Allworth Financial
Folsom,
California
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$4.14M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.3M |
| 3 |
KFI
Key Financial Inc
West Chester,
Pennsylvania
|
-$29K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$17.3K |
| 5 |
SIS
Sound Income Strategies
Ft Lauderdale,
Florida
|
-$16.8K |
PBPH Hedge Fund Activity: Q2 2026 in Review
9 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) for Q2 2026, worth a combined $855M — up 17% from $732M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PBPH and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Fisher Asset Management, adding an estimated $77.1M. The largest seller was Jane Street, cutting an estimated $4.14M.
- 9 institutional investors held Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) as of Q2 2026, down from 11 in Q1 2026.
- Funds reported $855M of Portfolio Building Block World Pharma and Biotech Index ETF stock for Q2 2026, up 17% quarter-over-quarter.
- 5 funds opened new Portfolio Building Block World Pharma and Biotech Index ETF positions in Q2 2026 and 6 closed out, a net change of -1 holder.
- The largest Portfolio Building Block World Pharma and Biotech Index ETF buyer in Q2 2026 was Fisher Asset Management, an estimated $77.1M added.
- The largest Portfolio Building Block World Pharma and Biotech Index ETF seller in Q2 2026 was Jane Street, an estimated $4.14M sold.
Based on aggregated 13F filings for Q2 2026.